Kallis, Karoline
Conlin, Christopher C.
Zhong, Allison Y.
Hussain, Troy S.
Chatterjee, Aritrick
Karczmar, Gregory S.
Rakow-Penner, Rebecca
Dale, Anders M.
Seibert, Tyler M. http://orcid.org/0000-0002-4089-7399
Funding for this research was provided by:
Foundation for the National Institutes of Health (NIH/NIBIB K08EB026503, NIH UL1TR000100)
American Society for Radiation Oncology
Prostate Cancer Foundation
Article History
Received: 19 December 2023
Accepted: 10 June 2024
First Online: 8 July 2024
Declarations
:
: This retrospective study was approved by the institutional review board at UC San Diego (IRB 805394). The research was performed in accordance with the Declaration of Helsinki, and all relevant regulations. A waiver of consent was approved by the institutional review board for this study as there was minimal risk of harm to patients.
: Not applicable.
: AMD is a Founder of and holds equity in CorTechs Labs, Inc, and serves on its Scientific Advisory Board. He is a member of the Scientific Advisory Board of Human Longevity, Inc. and receives funding through research agreements with General Electric Healthcare. RRP is a consultant for Human Longevity, Inc. She also receives funding through research grants from GE Healthcare and Imagine Scientific to UC San Diego; she has an equity interest in CorTechs Labs, Inc. and serves on its Scientific Advisory Board. She also has equity interest in CureMetrix. TMS reports honoraria from Multimodal Imaging Services Corporation, Varian Medical Systems, and WebMD; he has an equity interest in CorTechs Labs, Inc. and serves on its Scientific Advisory Board. These companies might potentially benefit from the research results. The terms of the above arrangements have been reviewed and approved by the University of California San Diego in accordance with its conflict-of-interest policies. Drs. Chatterjee and Karczmar report equity in QMIS LLC, outside the submitted work.